KIFC1 and neoplasm: Our results provide insights into how tumors acquire the high risk of recurrence and therapeutic resistance via activating centrosome clustering, and reveal that blocking KIFC1 phosphorylation may serve as a promising therapeutic strategy for reducing the risk of tumor metastasis and recurrence.